Journal Mobile Options
Table of Contents
Vol. 21, No. 2, 2006
Issue release date: January 2006
Dement Geriatr Cogn Disord 2006;21:59–64

Early-Onset Dementia: Frequency and Causes Compared to Late-Onset Dementia

McMurtray A. · Clark D.G. · Christine D. · Mendez M.F.
V.A. Greater Los Angeles Healthcare System and Department of Neurology, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Research on the epidemiology of dementia has focused on the elderly. Few investigations have studied differences in etiologic frequencies between early-onset dementia (EOD), with onset at an age of less than 65 years old, and the more common late-onset disorder. Objectives: To determine relative frequencies and characteristics of EOD versus late-onset dementia (LOD; age of onset ≧65 years) diagnosed in a large memory disorders program over a 4-year period. Methods: We reviewed medical records, including an extensive neurobehavioral and neurological evaluation, of all patients seen at a large Veteran’s Affairs Medical Center Memory Disorders clinic between 2001 and 2004 and assessed demographic variables, final diagnoses, presence of dementia, and differential diagnosis of dementing illnesses. Results: Among 1,683 patients presenting for evaluation of an acquired decline in memory or cognition, 948 (56%) met established clinical criteria for a dementing illness. About 30% (n = 278) of these had an age of onset of <65 years, compared to 670 with LOD. Patients were predominantly male (98%). Compared to the late-onset group, the EOD patients were less severely impaired on presentation, but they did not differ in gender distribution or educational background. The EOD group had significantly more dementia attributed to traumatic brain injury, alcohol, human immunodeficiency virus (HIV), and frontotemporal lobar degeneration compared to the LOD patients. In contrast, the LOD group had significantly more Alzheimer’s disease compared to the EOD group. Conclusions: This study, conducted at a Veterans Affairs Hospital, is the largest series to date on EOD, and found a previously unexpectedly large number of patients below the age of 65 with cognitive deficits and impaired functioning consequent to head trauma, alcohol abuse, and HIV. These findings highlight the differential distribution and importance of preventable causes of dementia in the young.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Sampson EL, Warren JD, Rossor MN: Young onset dementia. Postgrad Med J 2004;80:125–139.
  2. Harvey RJ, Skelton-Robinson M, Rossor MN: The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 2003;74:1206–1209.
  3. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133–1142.
  4. American Psychiatric Association: Diagnostic and Statistic Manual, ed 4. Washington, American Psychiatric Association Press, 1994.
  5. Mendez MF, Cummings JL: Dementia. A Clinical Approach, ed 3. Philadelphia, Elsevier, 2003.
  6. World Health Organization: International Classification of Disease, ed 10. Geneva, World Health Organization, 1992.
  7. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  8. McGonigal G, Thomas B, McQuade C, Starr JM, MacLennan WJ, Whalley LJ: Epidemiology of Alzheimer’s presenile dementia in Scotland, 1974–88. BMJ 1993;306:680–683.
  9. Newens AJ, Forster DP, Kay DW, Kirkup W, Bates D, Edwardson J: Clinically diagnosed presenile dementia of the Alzheimer’s type in the Northern Health Region: ascertainment, prevalence, incidence, and survival. Psychol Med 1993;23:631–644.
  10. Treves T, Korczyn ADK, Zilber N, Kahana E, Leibowitz Y, Alter M, Schoenberg BS: Presenile dementia in Israel. Arch Neurol 1986;43:26–29.
  11. Hoffman A, Rocca WA, Brayne C, Breteler MM, Clarke M, Cooper B, Copeland JR, Dartigues JF, da Silva Droux A, Hagnell O: The prevalence of dementia in Europe: a collaborative study of 1980–1990 findings. Int J Epidemiol 1991;20:736–748.
  12. Kokmen E, Beard CM, Offord KP, Kurland LT: Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975. Neurology 1989;39:773–776.
  13. Ratnavalli E, Brayne C, Dawson K, Hodges JR: The prevalence of frontotemporal dementia. Neurology 2002;58:1615–1621.
  14. Harvey RJ, Rossor MN, Skelton-Robinson M: Young Onset Dementia: Epidemiology, Clinical Symptoms, Family Burden, Support and Outcome. London, Dementia Research Group, 1998.
  15. Fujihara S, Brucki SM, Rocha MS, Carvalho AA, Picccolo AC: Prevalence of presenile dementia in a tertiary outpatient clinic. Arq Neuropsiquiatr 2004;62:592–595.
  16. Panegyres PK, Davies SR, Connor CF: Early-onset dementia. Med J Aust 2000;173:279–280.
  17. Elberling TV, Stokholm J, Hogh P, Waldemar G: Diagnostic profile of young and middle-aged memory clinic patients. Neurology 2002;59:1259–1262.
  18. Woodburn K, Johnstone E: Ascertainment of a population of people with early-onset dementia in Lothian, Scotland. Int J Geriatr Psychiatry 1999;14:362–367.
  19. Delaney N, Rosenvinge H: Presenile dementia: suffers, careers and services. Int J Geriatr Psychiatry 1995;10:597–601.

    External Resources

  20. Varma AR, Adams W, Lloyd JJ, Carson KJ, Snowden JS, Testa HJ, Jackson A, Neary D: Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer’s disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand 2002;105:261–269.
  21. Ikeda M, Hokoishi K, Maki N, Nebu A, Tachibana N, Komori K, Shigenobu K, Fukuhara R, Tanabe H: Increased prevalence of vascular dementia in Japan: a community-based epidemiological study. Neurology 2001;57:839–844.
  22. Ferran J, Wilson K, Doran M, Ghadiali E, Johnson F, Cooper P, McCracken C: The early onset dementias: a study of clinical characteristics and service use. Int J Geriatr Psychiatry 1996;11:863–869.

    External Resources

  23. Knopman DS, Petersen RC, Edland SD, Rocca WA: The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 2004;62:506–508.
  24. Nestor P, Hodges J: Non-Alzheimer dementias. Semin Neurol 2000;20:439–446.
  25. Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, Chute DJ, Roberson ED, Pace-Savitsky C, Neumann M, Chow TW, Rosen HJ, Forstl H, Kurz A, Miller BL: Frontotemporal lobar dementia: demographic characteristics across three sites. Arch Neurol 2005;62:925–930.
  26. Smith DM, Atkinson RM: Alcoholism and dementia. Int J Addict 1995;30:1843–1869.
  27. McKeith IG, Perry EK, Perry RH: Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on dementia with Lewy bodies. Neurology 1999;53:902–905.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50